Evidence-based dermatology aims to optimize patient care by integrating clinical practice with robust, critically appraised research while considering individual patient needs and values. Dr. Linnea Thorlacius, a part-time postdoctoral researcher and clinician, specializes in patient-centered outcome measurement in clinical trials and treatment, with a particular focus on complex dermatological conditions such as hidradenitis suppurativa (HS) and hyperhidrosis. Her research emphasizes clinimetrics and collaboration with patient research partners to en-hance both clinical research and patient care. For the past three years, Dr. Thorlacius has served as an associate editor for the British Journal of Dermatology's Qualitative and Out-comes Research section. As she approaches the completion of her dermatology residency, she remains dedicated to integrating clinical practice with innovative research to advance patient care.
Dr. Thorlacius is leading efforts to establish a Centre of Expertise in Outcome Measurements in Dermatology at the Department of Dermatology, Zealand University Hospi-tal, Roskilde. Through her leadership, the group has initiated a direct collaboration and affilia-tion with Section for Biostatistics and Evidence-Based Research at the Parker Institute, lever-aging the team’s expertise in biostatistics and clinical epidemiology. This collaboration brings together methodologists with extensive experience in designing, analyzing, and interpreting clinical research with a global outreach.
Internationally, Dr. Thorlacius and Section for Biostatistics and Evidence-Based Research will be involved in initiatives aimed at standardizing outcome measures in dermatol-ogy, including the HISTORIC (HIdradenitis SuppuraTiva cORe outcomes set International Collaboration) project and the C3 (CHORD COUSIN Collaboration) consortium. These efforts unite global stakeholders to advance dermatological outcome measurement. Their contribu-tions include co-leading the HISTORIC consensus process, which previously defined core